В. А. Марков
- Internal Medicine top 2%
- Venous Thromboembolism Diagnosis and Management 3
-
- Acute Myocardial Infarction Research 17
- Cardiovascular Function and Risk Factors 3
- Viral Infections and Immunology Research 3
-
- Cardiac Imaging and Diagnostics 8
-
- Coronary Interventions and Diagnostics 3
-
- Healthcare Systems and Public Health 4
-
- Mesenchymal stem cell research 2
- Co-authors
- Frank MisselwitzPascual BordesPaul BurtonRohan PoulterC. Michael GibsonEugene BraunwaldSatishkumar MohanaveluLeonard Oppenheimer
- Journals
- Pacing and Clinical Electrophysiology (1 paper)Circulation Heart Failure (1 paper)The Lancet (1 paper)
- Partner nations
- RussiaGermanyUnited States
In The Last Decade
В. А. Марков
30 papers receiving 786 citations
Hit Papers
Peers
Comparison fields: 5 of 62
- Internal Medicine 272
- Cardiology and Cardiovascular Medicine 736
- Hematology 49
- Radiology, Nuclear Medicine and Imaging 93
- Surgery 122
Countries citing papers authored by В. А. Марков
This map shows the geographic impact of В. А. Марков's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by В. А. Марков with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites В. А. Марков more than expected).
Fields of papers citing papers by В. А. Марков
This network shows the impact of papers produced by В. А. Марков. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by В. А. Марков. The network helps show where В. А. Марков may publish in the future.
Co-authorship network
The 25 scholars most cited alongside В. А. Марков, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 10 | |
| 2 | 2019 | 3 | |
| 3 | 2018 | 1 | |
| 4 | 2018 | 10 | |
| 5 | 2018 | 1 | |
| 6 | 2017 | 7 | |
| 7 | 2017 | 3 | |
| 8 | 2016 | 1 | |
| 9 | 2015 | 0 | |
| 10 | 2015 | 4 | |
| 11 | 2015 | 1 | |
| 12 | 2014 | 0 | |
| 13 | 2012 | 3 | |
| 14 | 2009 | 2 | |
| 15 | Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trialbreakdown → | 2009 | 488 |
| 16 | 2005 | 34 | |
| 17 | [The protective effect of trimetazidine on the myocardium against reperfusion injury during thrombolytic therapy of acute infarction]. | 2004 | 3 |
| 18 | 2002 | 4 | |
| 19 | [Relation between the systemic fibrinolytic status and coronary reperfusion during thrombolytic therapy with streptokinase of patients with acute myocardial infarction]. | 1989 | 0 |
| 20 | 1986 | 1 |
About В. А. Марков
В. А. Марков is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Radiology, Nuclear Medicine and Imaging, having authored 38 papers that have together received 814 indexed citations. Recurring topics across this work include Acute Myocardial Infarction Research (17 papers), Cardiac Imaging and Diagnostics (8 papers), Healthcare Systems and Public Health (4 papers), Cardiovascular Function and Risk Factors (3 papers), Viral Infections and Immunology Research (3 papers), Coronary Interventions and Diagnostics (3 papers), Venous Thromboembolism Diagnosis and Management (3 papers) and Mesenchymal stem cell research (2 papers). The work is most often cited by research in Internal Medicine (272 citations), Cardiology and Cardiovascular Medicine (736 citations) and Hematology (49 citations). В. А. Марков has collaborated with scholars based in Russia, Germany and United States. Frequent co-authors include Frank Misselwitz, Pascual Bordes, Paul Burton, Rohan Poulter, C. Michael Gibson, Eugene Braunwald, Satishkumar Mohanavelu, Leonard Oppenheimer, V. Hricak and Adam Witkowski. Their work appears in journals such as Pacing and Clinical Electrophysiology, Circulation Heart Failure, The Lancet, PLoS ONE and Bulletin of Experimental Biology and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.